SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Trading 2.8% Higher – Here’s Why

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) shot up 2.8% on Thursday . The company traded as high as $67.17 and last traded at $67.16. 87,085 shares traded hands during trading, an increase of 5% from the average daily volume of 83,059 shares. The stock had previously closed at $65.32.

SPDR S&P Pharmaceuticals ETF Stock Up 2.8%

The firm has a market cap of $409.68 million, a P/E ratio of 14.28 and a beta of 0.58. The stock’s 50-day simple moving average is $59.49 and its 200 day simple moving average is $57.21.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Turtle Creek Wealth Advisors LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF during the first quarter worth approximately $26,000. Western Wealth Management LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $34,000. Advisory Services Network LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $34,000. Fifth Third Bancorp acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $39,000. Finally, Team Financial Group LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $56,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.